Share 'Race-based medicine on its way'

Differences in response to medical products have been observed in racially and ethnically distinct subgroups of the US population. Approved doses and dosing regimens for some of the most widely prescribed drugs have also been shown to be different in different countries (e.g., the United States, the United Kingdom, and Japan). These differences may be attributable to intrinsic ethnic factors (e.g…